Symrise stock: At EUR 99.55, Symrise stock sits 1.24 percent below its 52-week high
Published on 10/19/2026 at 16:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMarket level and next report
- Symrise stock stood 1.24 percent below its 52-week high on October 19, 2026.
- Fiscal 2025 revenue reached EUR 4.929 billion, with organic growth of 2.80 percent.
- Symrise stock costs EUR 99.55 at Lang & Schwarz on October 19, 2026 at 4:04 p.m. CEST, 0.11 percent above the Xetra close of October 16, 2026.
- The next reporting date is October 28, 2026, while the price-to-earnings ratio is 37.41.
Near its yearly peak, Symrise stock stood 1.24 percent below the EUR 100.80 52-week high on October 19, 2026. The price was EUR 99.55 at Lang & Schwarz at 4:04 p.m. CEST, up 0.11 percent versus the Xetra close of October 16, 2026.
Revenue provides the operating base
Symrise reported EUR 4.929 billion in fiscal 2025 revenue and 2.80 percent organic growth. The company also reported a 21.90 percent EBITDA margin for the year, excluding the impairment of its associate Swedencare, according to Symrise.
The investor-relations calendar lists the third-quarter 2026 interim communication for October 28, 2026. The same date is also listed for a virtual management roadshow, giving the next clearly dated company event.
Price position near the yearly high
The current euro quotation is EUR 1.25 below the 52-week high of EUR 100.80 and EUR 34.85 above the 52-week low of EUR 64.70. That places the stock near the upper end of its annual range, while the price-to-earnings ratio of 37.41 provides the main valuation marker in the current market picture. Trading volume was 134,669 shares against an average of 315,800 shares at the latest finance-data timestamp on October 19, 2026.
Bernstein Research rated Symrise Market-Perform with a EUR 99.00 target after investor meetings in North America, as FinanzNachrichten reported on October 13, 2026. The current Lang & Schwarz price is 0.56 percent above that target, calculated in euros.
Comparison with peers
Symrise: plus 0.11 percent, P/E 37.41, market capitalization EUR 13.7 billion.
Givaudan (SIX, CHF): plus 0.72 percent, P/E 29.28, market capitalization CHF 36.4 billion.
DSM-Firmenich (Euronext Amsterdam, EUR): plus 1.45 percent, P/E minus 22.53, market capitalization EUR 26.5 billion.
Next report sets the calendar
For investors, the October 28, 2026 reporting date is the next concrete checkpoint. The combination of a price near the annual high, a 37.41 price-to-earnings ratio and the upcoming interim communication makes the reporting date more relevant than a short intraday move.
Market level and investor view
Symrise stock was trading at EUR 99.55 at Lang & Schwarz on October 19, 2026 at 4:04 p.m. CEST, 0.11 percent above the Xetra close of October 16, 2026 at EUR 99.44. The current quote is 1.24 percent below the 52-week high of EUR 100.80.
The further course of trading is shown by the continuously updated real-time quote of Symrise stock.
Symrise market data
- Company: Symrise AG
- ISIN: DE000SYM9999
- WKN: SYM999
- Ticker: SY1
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 19, 2026, 4:04 p.m. CEST): EUR 99.55
- Change versus Xetra close: plus 0.11 percent
- Xetra close (October 16, 2026): EUR 99.44
- Market capitalization: EUR 13.7 billion (as of October 19, 2026)
- 52-week range: EUR 64.70-100.80 (as of October 19, 2026)
- Sector / Industry: Basic Materials / Specialty Chemicals
- Index membership: DAX
- Next earnings date: October 28, 2026
Market context: Market report DAX.
